Corporate Tech Investors

Celgene

Celgene is a corporate venture capital group that partners with firms that align with the company's business objectives.

Venture Investor Overview

Venture Investor
Celgene
Status
InActive
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical

Contact Information

Contact
Mark Alles
Title
Chief Executive Officer
Mailing Address
86 Morris Ave.
Summit, NJ 07901
USA
Email Address

Background Information

Overview
Celgene Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases in Europe and the United States.
Profile
Celgene LinkedIn Company Profile
Social Media
Celgene Company Twitter Account
Company News
Celgene News
Facebook
Celgene on Facebook
YouTube
Celgene on YouTube
Last Transaction
10/16/2019

Transaction History

Our records indicate that Celgene invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
10/16/2019
$40,200,000
8/22/2019
$79,500,000
8/8/2019
$12,000,000
7/10/2019
$23,000,000
6/19/2019
$37,000,000
5/1/2019
$82,000,000
4/19/2019
$75,000,000
2/8/2019
$60,750,000
1/7/2019
$65,000,000
9/20/2018
$47,500,000
7/30/2018
$85,400,000
7/18/2018
$6,000,000
5/16/2018
$45,000,000
3/16/2018
$94,000,000
3/9/2018
$29,000,000
3/6/2018
Unknown
2/16/2018
$250,000,000
12/22/2017
$60,000,000
11/14/2017
$107,000,000
7/12/2017
$50,000,000
6/23/2017
$68,000,000
5/9/2017
$23,000,000
3/3/2017
$900,000,000
2/28/2017
$38,000,000
8/30/2016
$120,000,000
8/9/2016
$37,000,000
7/20/2016
$57,000,000
5/18/2016
$10,600,000
5/5/2016
$46,000,000
4/30/2016
$50,000,000
4/5/2016
$220,000,000
2/10/2016
$50,000,000
1/8/2016
$61,500,000
12/8/2015
$10,000,000
4/30/2015
$41,800,000
4/30/2015
$64,000,000
12/19/2014
$38,000,000
10/20/2014
Unknown
6/10/2014
$25,000,000
1/10/2014
$13,500,000
12/18/2013
$38,500,000
12/11/2013
$26,000,000
10/8/2013
$45,000,000
7/30/2013
$100,000,000
3/8/2013
$60,000,000
7/24/2012
$30,000,000
2/9/2012
$15,000,000
12/23/2011
$30,000,000
11/17/2011
$78,000,000
12/23/2009
$50,000,000
9/26/2007
$41,200,000

 


Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Mark Alles
  Mark Alles LinkedIn Profile  Mark Alles Twitter Account  Mark Alles News  Mark Alles on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Celgene has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

Cedars-Sinai Medical Center | Cemex Ventures

 

Share this article

 


About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary